International Journal of Preventive Medicine, 2023 Background: Antiemetic medications have been associated with the prevention of nausea and vomiting in cesarean section, although less is known about the comparative efficacy of different medication classes.
Zoleykha Asgarlou +6 more
doaj +1 more source
Effects of ginger and ondansetron on intra and postoperative nausea and vomiting in cesarean section under spinal anesthesia: A double-blinded randomized clinical trial [PDF]
Journal of HerbMed Pharmacology, 2023 Introduction: The occurrence of nausea and vomiting following anesthesia and surgery is a prevalent and distressing issue, ranking second only to pain.
Behzad Imani +3 more
doaj +1 more source
Cannabinoid Hyperemesis Syndrome [PDF]
, 2015 Legalization of marijuana use will increase the number of people who will become long-term users. A prior medical record review study in Australia, in 2004, identified 19 chronic marijuana users who entered the emergency department with recurrent ...
Heise, Lynn
core +2 more sources
Ramosetron for the prevention of postoperative nausea and vomiting (PONV): a meta-analysis [PDF]
Korean Journal of Anesthesiology, 2011 BackgroundPostoperative nausea and vomiting (PONV) remains a challenge for patients and health professionals despite various newly developed prophylactic interventions.
Won Oak Kim +3 more
doaj +1 more source
Postdischarge nausea and vomiting (PDNV) in children: A review and observational study
Biomedical Papers, 2023 Postdischarge nausea and vomiting (PDNV) cause substantial pediatric morbidity with potentially serious postoperative complications. However, few studies have addressed PDNV prevention and treatment in pediatric patients.
Michal Frelich +6 more
doaj +1 more source
Applicability of the National Comprehensive Cancer Network/Multinational Association of Supportive Care in Cancer Guidelines for Prevention and Management of Chemotherapy-Induced Nausea and Vomiting in Southeast Asia: A Consensus Statement. [PDF]
, 2017 A meeting of regional experts was convened in Manila, Philippines, to develop a resource-stratified chemotherapy-induced nausea and vomiting (CINV) management guideline. In patients treated with highly emetogenic chemotherapy in general clinical settings,
Abdullah, Matin M +5 more
core +2 more sources
The impact of 5-hydroxytryptamine-receptor antagonists on chemotherapy treatment adherence, treatment delay, and nausea and vomiting. [PDF]
, 2015 PurposeTo determine the incidence of chemotherapy-induced nausea/vomiting (CINV) and chemotherapy treatment delay and adherence among patients receiving palonosetron versus other 5-hydroxytryptamine receptor antagonist (5-HT3 RA) antiemetics.Materials ...
Grabner, Michael +3 more
core +2 more sources
In Vivo, 2019 Background/Aim: Although neurokinin-1 receptor antagonists are approved chemotherapy drugs in Japan, no nationwide surveys have been performed to validate chemotherapy-induced nausea and vomiting (CINV) guidelines in clinical practice.
I. Yoshida +15 more
semanticscholar +1 more source
Antiemetic research: future directions [PDF]
, 2010 PURPOSE AND METHODS: As a part of reviewing the Multinational Association of Supportive Care in Cancer (MASCC) antiemetic guidelines in Perugia in 2009, an expert group identified directions for future antiemetic research.
Aapro, Matti +5 more
core +1 more source
Recent advances in antiemetics: new formulations of 5HT3-receptor antagonists
Cancer Management and Research, 2018 Purpose To discuss new therapeutic strategies for chemotherapy-induced nausea and vomiting (CINV) involving 5-hydroxytryptamine type 3 (5HT3)-receptor antagonists (RAs).
J. Gilmore +3 more
semanticscholar +1 more source